Home / Technology / AI Agents: Beyond Perfect Scores to Real Product Health
AI Agents: Beyond Perfect Scores to Real Product Health
21 Jul
Summary
- Enterprises now compare user cohorts, not just single AI conversations.
- Evaluation criteria are evolving into living product specifications.
- Hybrid approach combines scalable AI judging with essential human oversight.
The evaluation of AI agents is undergoing a significant transformation. Enterprises are moving away from assessing individual conversation traces, which can appear flawless yet mask underlying product issues. Instead, the focus is shifting towards comparing cohorts of users against established baselines to gauge true product performance.
This evolution means that evaluation criteria are now functioning as dynamic product specifications, akin to traditional PRDs. Experts highlight that successful teams launch products and iterate based on real-world performance, rather than striving for complete pre-launch test coverage, which can lead to 'eval paralysis'.
Furthermore, the industry is witnessing a trend towards more cost-effective, specialized judge models. While LLM-as-judge remains a default, the tension between automated judging and human review persists. Scalable AI judges offer broad insights but may lack grounding, making human review indispensable for accountability and trust, particularly in sensitive sectors like legal, finance, and healthcare.
This hybrid approach leverages AI for widespread monitoring and identifying failure classes. Targeted offline evaluations are then built around surfacing issues. The goal is to strike a balance, using AI for scale while retaining human judgment for critical sign-offs and building overall system trust and memory.
